FindTrial
Sign In

A medical records based study for the influence of novel coronavirus pneumonia (COVID-19) on the symptoms of patients with achalasia

The influence of novel coronavirus pneumonia (COVID-19) on the symptoms of patients with achalasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033919
Enrollment
Unknown
Registered
2020-06-17
Start date
2020-06-16
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Have undergone POEM :Questionnaire
Have not undergone POEM :Questionnaire

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with achalasia were diagnosed through gastroscopy, high-resolution esophageal manometry, and angiography; 2. Aged 18–65 years; 3. education above primary school; 4. no history of digestive system diseases.

Exclusion criteria

Exclusion criteria: 1. refused the study; 2. abnormal vision; 3. Nervous system disease that affffects the ability to understand.

Design outcomes

Primary

MeasureTime frame
Eckardt score;Hospital Anxiety and Depression Scale;Diet self-evaluation;—

Countries

China

Contacts

Public ContactWei Zhao

Tianjin Medical University General Hospital

zhaoweihotstone@yeah.net+86 15022327482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026